Overall rank by patents
#10,120
of 50,000 tracked assignees
USPTO PatentsView assignee record - 31 granted patents across 10 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
According to USPTO PatentsView, Norton ranks #10,120 of 50,000 tracked US assignees by granted-patent volume, with 31 patents across 10 technology areas.
USPTO PatentsView assignee plate
Corpus R10120 · Foreign Corporation #10,120 · 31 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Neptune Technology Group Llc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
ADEY Holdings (2008) · near
46 score
Goodrich Actuation S… · near
46 score
Integrated Roadways · near
46 score
Norton Healthcare · this assignee
46 score
Shenzhen Poweroak Ne… · near
46 score
3D Lighting Innovati… · lowest
7 score
What this shows Norton Healthcare Limited stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, VEL-FLAT, BOOK-FULL. Volume places it #10,120 of 50,000; Innovation Score 45.6/100 sits in the top 23% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Neptune Technology Group Llc (±0 grants).
Norton Healthcare Limited has been granted 31 US utility patents between 2015 and 2024, placing Norton Healthcare Limited at #10,120 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.0 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Norton Healthcare Limited is one of the more focused assignees in the PatentsView dataset. By volume, Norton sits between Neptune Technology Group Llc (31 patents, rank #10,116) and Octapharma Ag (31 patents, rank #10,124) - the closest US assignees by grant volume. The composite Innovation Score of 45.6/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 16 grants, compared with 15 in the 2015–2019 window, a +7% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Norton Healthcare Limited's 18.0 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 10 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Neptune Technology Group LLC
31 patents
Nevermind Capital LLC
31 patents
NewLeaf Symbiotics, Inc.
31 patents
Nordco Inc.
31 patents
Novo Nordisk Health Care AG
31 patents
Novus International, Inc.
31 patents
Nytell Software LLC
31 patents
OCTAPHARMA AG
31 patents
Norton Healthcare Limited
31 patents
What this shows Norton holds 31 patents at rank #10,120, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #10,120 in granted patent volume.
Other assignees with the most granted patents in Norton's primary technology class.
Two PlainPatent-derived peer sets for Norton, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (46 here).
Norton's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 23% higher than 77% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 6.5% |
| 2016 | 2 | 6.5% |
| 2017 | 2 | 6.5% |
| 2018 | 3 | 9.7% |
| 2019 | 6 | 19.4% |
| 2020 | 1 | 3.2% |
| 2021 | 1 | 3.2% |
| 2022 | 12 | 38.7% |
| 2023 | 1 | 3.2% |
| 2024 | 1 | 3.2% |
Top 10 of 10 technology areas
Overall rank by patents
#10,120
of 50,000 tracked assignees
45.6 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.